(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 6.04% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.27%.
Stepan Co's revenue in 2026 is $2,432,788,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $57,672,453,980, with the lowest SCL revenue forecast at $55,285,537,280, and the highest SCL revenue forecast at $60,695,881,800. On average, 3 Wall Street analysts forecast SCL's revenue for 2027 to be $61,218,730,220, with the lowest SCL revenue forecast at $58,490,825,420, and the highest SCL revenue forecast at $64,628,611,220.
In 2028, SCL is forecast to generate $66,288,086,640 in revenue, with the lowest revenue forecast at $64,333,088,200 and the highest revenue forecast at $68,925,061,280.